InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: manisero66 post# 6120

Thursday, 04/13/2017 1:27:57 PM

Thursday, April 13, 2017 1:27:57 PM

Post# of 8022
I don't understand your post.
They already received fast track


Vericel Receives FDA Fast Track Designation for Ixmyelocel-T
7:41 am ET February 21, 2017 (Benzinga) Print

Vericel Corporation (NASDAQ: VCEL), a leading developer of autologous expanded cell therapies for the treatment of patients with serious diseases and conditions, today announced that the U.S. Food and Drug Administration (FDA) has designated the investigation of ixmyelocel-T for reduction in the risk of death and cardiovascular hospitalization in patients with chronic advanced heart failure due to ischemic dilated cardiomyopathy as a Fast Track Development Program.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News